Johnson & Johnson Vision, a global leader in eye health, announced the launch of TECNIS Eyhance intraocular lens (IOL), a superior monofocal IOL implant for patients who have undergone cataract removal surgery procedures. The TECNIS Eyhance IOL is an important first for the monofocal category, ...
The TECNIS PC-IOL Portfolio Powered by InteliLight delivers the best* contrast and low-light performance across the PC-IOL category1,2,3 TECNIS Symfony OptiBlue is now available in the U.S. and select countries in EMEA
a global leader in eye health, today announced the launch of its TECNIS Eyhance IOL for the treatment of cataracts inEurope. This next-generation monofocal intraocular lens (IOL) allows patients to experience high-qua...
Johnson & Johnsonscientists are usingprecision medicine technology to developand refinenovel treatments for diseasesof the cardiovascular system, immune system and neurological system, as well as for pulmonary hypertension, infectious diseases, oncology and more. 10. A possible way to catch Alzheimer’s ...
Johnson & Johnson (JNJ) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Eye surgery, Ophthalmology, Disorders of sclera and cornea, Diseases of the eye and adnexa, Vision Grant LatestJohnson & Johnson VisionNews Variety of scleral fixation techniques can replace or rescue IOL Jan 9, 2025 Add topic to email alerts Receive an email when new articles are posted on Pl...
Johnson & Johnson Vision, a global eye health company, said it launched new intraocular lens for cataract surgery and laser vision correction equipment in Korea.The company held a press conference in southern Seoul on Thursday to celebrate the release of
” said Dr. Ike Ahmed, Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship, University of Toronto in Canada. “Having used the TECNIS Toric II platform in other TECNIS lenses, I'm eager to use the TECNIS Synergy Toric II IOL in patients that require ...
Johnson & Johnson announced results for third-quarter 2022. “Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses,” said Joaquin Duato, Chief Executive Officer.
Johnson and Johnson Vision Care operates within the healthcare industry, providing products and services for managing eye conditions like myopia, presbyopia, astigmatism, and cataracts, along with vision correction and eye care education. The company serves the healthcare sector, focusing on ophthalmology...